Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “German Society for Humane Dying”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 19 recordsLinked to original sources
PubMed1991

Euthanasia: the way we do it, the way they do it.

Although the Netherlands, Germany, and the United States are alike in having aging populations who die primarily of deteriorative diseases, they face end-of-life dilemmas quite differently. In the United States, withholding and withdrawing of treatment are the only legally recognized means for easing dying. In Holland, voluntary active euthanasia is also practiced; in (West) Germany, assisted suicide is a legal option, usually outside the medical setting. This paper examines objections to these three practices, and observes the differences in the background cultures. Rather than reliance on any of the three, it argues that physician-assisted suicide in terminal illness is the practice most compatible with the United States' special characteristics.

Attitude to Death↗
PubMed1993

Stroke research.

Explore the source record for details and available documents.

Cerebrovascular Disorders↗
PubMed1984

[Walter Siegried Loewe (1884-1963). His contribution to the analysis, biology and pharmacology of sex hormones].

Walter Siegfried Loewe was born on August 19, 1884, in Fürth, Bavaria. The centenary of his birth should be of interest to pharmacologists, endocrinologists and clinical chemists, alike. In this short review an attempt has been made to describe the contributions of Loewe and his coworkers to the biochemistry and analysis of the sex hormones. Loewe began his research on dose effect-response of ovarian extracts at the University of Dorpat, Estonia. By quantification of the Allen-Doisy-test, Loewe was the first to succeed in measuring oestrogens in human blood and urine. Further scientific research was focussed on the content and the local effects of oestrogens within the placenta. In the same time, Loewe and his coworker Voss developed the first, specific bioassay for the male hormone. It was based on the histological repair of the epithelium of the seminal vesicles in castrated mice, brought about by the injection of testicle extracts. With the aid of this so-called "cytological regeneration test" Loewe was able to isolate and characterize androgens from different biological sources. The male hormone was called "androkinin", and in 1928 Loewe reported the occurrence of androkinin in human male urine and its separation from oestrogens in the same material. On the basis of the early mitogenic effect of androgens the bioassay of Loewe & Voss was further improved, serving as a fundamental prerequisite for the isolation and chemical charcterization of the androgens in the early thirties. Loewe who had held the chair of pharmacology at Dorpat since 1921, came to Mannheim in 1928 as head of the Main Laboratory of the Municipal Hospital. In 1933 he was forced to emigrate, went first to Cornell-University, New York and later to the Department of Pharmacology at the University of Utah. In 1948 he became an honorary member of the German Pharmacological Society and in 1960 of the German Society of Endocrinology. Three years later, on August 24, 1963 at Salt Lake City, Loewe died at the age of 79 years.

Animals↗
PubMed2005

[Dehydration. Ethical standards finding in the social controversy].

Three case histories are presented, in which terminal hydration was omitted. Two patients were in the terminal phase of a menigiosis carcinomatosa and Creutzfeldt-Jacob disease, the third was completely aphasic and hemiplegic after ischemic stroke. All three died peacefully without signs of suffering or thirst. The psychological aspects of therapeutic-palliative change and the archetypical horror of death are considered. The moral justification is discussed in relation to the "Principles for Physicians Accompanying the Dying" of the German chamber of physicians. The respect of the patient's will is the guiding principle. These ethical controversies should be discussed sincerely and frankly so that the society is enabled to follow.

Aged↗
PubMed1993

[Woman and race biology].

Early 20th century race biology takes a special interest in woman as part of the "intra-racial" project of bringing forth healthy and competitive individuals. But there are other motives as well for the race biologist to take an interest in woman. She is believed to develop fewer individual characteristics and is therefore a more typical representative of her race than man. The development level of the race is also presupposed to be discernible by the degree of "gender diformism": a race of higher standing would exhibit a greater difference between the sexes. The anthropologist, anatomist, gynaecologist--or whatever guise the race biologist may adopt-- will, in principle, stress that the relation between the sexes is not a matter of "more or less", but one of differences in kind. In reality, the "more-or-less of comparison is the very cornerstone of the issue. Quantitative differences, directly observed or obtained from statistics, are construed as signs of difference in kind. 18th century medical philosophy and sex-linked anthropology laid the theoretical foundation of the 19th century essentialist conception of woman, which is also that adopted by race biology. Eugenics of social Darwinist inspiration regarded prophylactic health care and social welfare programs with scepticism. A race biology founded on the man-woman dualism could sustain altogether different conclusions. An advanced culture calls for extensive division of labour. An extended childhood renders possible higher development but will also impose higher demands on woman. The protection of the female organism is thus an exigency for any people or race striving to survive and evolve. From society's care for the female organism health care for women and preventive maternity care will emerge. Race biology has been a preeminently German concern, as indicated by the selection of works taken to represent this perspective on woman: Bartels-Ploss' Das Weib, C.H. Stratz' Die Rassenschönheit des Weibes and Oskar Schultze's Das Weib: In anthropologischer und sozialer Betrachtung.

Eugenics↗
PubMed1993

[Adjuvant therapy of primary malignant melanoma with natural human interferon-beta. Significant survival advantage in 96 treated patients in comparison with 288 untreated symptomatic controls].

In the dermatological department of Dortmund's Municipal Medical Centre, between May 1986 and April 1991 a total of 105 patients with primary malignant melanoma (stage I) underwent adjuvant treatment with 5 million IU natural interferon beta as a 30-min i.v. infusion three times weekly for 6 months. During follow-up the patients were examined at short intervals and all recurrences and disease-related cases of death were documented up to September 1992. We evaluated the outcome of patients treated with interferon beta (n = 96 with valid notes of tumour thickness) compared with untreated historical controls (n = 288) matched for tumour thickness, localization, and sex, taken from the Central Malignant Melanoma Registry (CMMR) of the German Dermatological Society. Therefore, the main prognostic factors were identical between cases and controls. A computerized randomization was used to fit three control patients to each treated patient. Survival rate and recurrence-free survival were estimated in both groups for a period of 5 years. During the follow-up 3 patients died in the interferon beta group and the 5-year survival rate was 95%, as against 89% in the control group (P < 0.05 for difference between survival curves). Recurrence-free survival curves were also more favourable for interferon-treated patients than for the control group (P = 0.06). A detailed analysis of high-risk patients with tumour thickness of over 1.5 mm also demonstrated obviously better survival (5 years: 95% vs 77%; P = 0.012) and recurrence-free survival rates (5 years: 75% vs 53%; P < 0.05).(ABSTRACT TRUNCATED AT 250 WORDS)

Adolescent↗